878130C

C16-18:1 PE

Avanti Research^™ - A Croda Brand 878130C

• 別名: 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine
• 実験式（ヒル表記法）: C₃₉H₇₈NO₇P
• CAS番号: 119904-40-4
• 分子量: 704.01
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• 形状: liquid
• 包装: pkg of 1 × 1 mL (878130C-5mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 878130C
• 濃度: 5 mg/mL (878130C-5mg)
• 脂質タイプ: bioactive lipids; phosphoglycerides
• 輸送温度: dry ice
• 保管温度: −20°C
• SMILES記法: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COCCCCCCCCCCCCCCCC

詳細

アプリケーション

C16-18:1 PE or 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine has been used as a lipid standard in liquid chromatography with tandem mass spectrometry (LC-MS-MS) and LC-20AD prominence high performance liquid chromatography system to quantify glycerophosphoethanolamines.

包装

5 mL Clear Glass Sealed Ampule (878130C-5mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372
• 注意書き: P201 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
• ターゲットの組織: Central nervous system, Liver,Kidney
• 保管分類コード: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• 引火点(°F): does not flash
• 引火点(℃): does not flash